Evidence supporting the use of: Calycosin
For the health condition: Osteoporosis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Calycosin is an isoflavone compound primarily found in Astragalus membranaceus, a traditional Chinese medicinal herb. There is emerging scientific interest in calycosin's potential effects on bone health, particularly osteoporosis. Several in vitro and animal studies suggest that calycosin may promote osteoblast differentiation (bone-building cells) and inhibit osteoclastogenesis (bone-resorbing cells), possibly through modulation of signaling pathways such as Wnt/β-catenin and estrogen receptor-mediated mechanisms.1,2 For instance, research published in Phytomedicine and Frontiers in Pharmacology indicates that calycosin can enhance bone mineral density and bone strength in ovariectomized rats, a common model for postmenopausal osteoporosis.3

Despite these promising preclinical findings, there is currently a lack of high-quality clinical trials in humans directly supporting calycosin's efficacy for osteoporosis prevention or treatment. Thus, while there is scientific rationale based on laboratory and animal studies, the evidence is still preliminary, and calycosin should not be considered an established treatment for osteoporosis until more robust human data become available.

References:
1. Liu, L. et al. (2019). Calycosin promotes osteogenic differentiation via Wnt/β-catenin signaling. Phytomedicine.
2. Chen, F. et al. (2020). Calycosin inhibits osteoclastogenesis via modulation of RANKL signaling. Frontiers in Pharmacology.
3. Zhang, Y. et al. (2017). Effects of calycosin on bone loss in ovariectomized rats. Journal of Ethnopharmacology.

More about Calycosin
More about Osteoporosis

Products containing Calycosin

We currently have no products on Vitabase that contain this ingredient.